Trident Lifeline soars on completing acquisition of 51% stake in TLL Herbal
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Trident Lifeline is currently trading at Rs. 223.30, up by 10.05 points or 4.71% from its previous closing of Rs. 213.25 on the BSE.
The scrip opened at Rs. 202.50 and has touched a high and low of Rs. 223.30 and Rs. 202.50 respectively. So far 70800 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 239.70 on 08-Aug-2023 and a 52 week low of Rs. 102.75 on 11-Oct-2022.
Last one week high and low of the scrip stood at Rs. 239.70 and Rs. 201.50 respectively. The current market cap of the company is Rs. 256.78 crore.
The promoters holding in the company stood at 70.04%, while Institutions and Non-Institutions held 4.36% and 25.60% respectively.
Trident Lifeline has completed acquisition of equity share equivalent to 51% of the total issued and paid up share capital of TLL Herbal, from the existing shareholders of TLL Herbal and making it a subsidiary company. Recently, the Board of Directors of the company had approved the acquisition of majority stake (51%) in TLL Herbal at their meeting held on July 15, 2023.
Earlier, the company had completed acquisition of 18% equity shares of Tricorp Industries (TIL) from the existing shareholders of TIL on July 25, 2023.
Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.
